BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kichloo A, Albosta M, Dahiya D, Guidi JC, Aljadah M, Singh J, Shaka H, Wani F, Kumar A, Lekkala M. Systemic adverse effects and toxicities associated with immunotherapy: A review. World J Clin Oncol 2021; 12(3): 150-163 [PMID: 33767971 DOI: 10.5306/wjco.v12.i3.150]
URL: https://www.wjgnet.com/2218-4333/full/v12/i3/150.htm
Number Citing Articles
1
Chung-Shien Lee, Nagashree Seetharamu. Cancer Treatment: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2023; 2: 267 doi: 10.1007/16833_2022_63
2
Philip N. Moquist, Xinqun Zhang, Chris I. Leiske, Nicole M.-L. Eng-Duncan, Weiping Zeng, Noah A. Bindman, Serena W. Wo, Abbie Wong, Clark M. Henderson, Karalyne Crowder, Robert Lyon, Svetlana O. Doronina, Peter D. Senter, Haley D. Neff-LaFord, Django Sussman, Shyra J. Gardai, Matthew R. Levengood. Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune ActivationBioconjugate Chemistry 2024;  doi: 10.1021/acs.bioconjchem.4c00212
3
Abhishek Jain, Amol Singam, V N K Srinivas Mudiganti. Newer Advancement in Immunomodulatory Therapy in Sepsis: A Comprehensive ReviewCureus 2024;  doi: 10.7759/cureus.57309
4
Oanh T. P. Nguyen, Patrick M. Misun, Christian Lohasz, Jihyun Lee, Weijia Wang, Timm Schroeder, Andreas Hierlemann. An Immunocompetent Microphysiological System to Simultaneously Investigate Effects of Anti-Tumor Natural Killer Cells on Tumor and Cardiac MicrotissuesFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.781337
5
Anna Lea Amylidi, Aristeidis Gogadis, Melina Yerolatsite, George Zarkavelis, Nanteznta Torounidou, Varvara Keramisanou, Eleftherios Kampletsas, Davide Mauri. Exploring a Rarity: Incidence of and Therapeutic Approaches for Neurological Complications and Hypophysitis in Cancer Patients on Immune Checkpoint Inhibitors—A Single-Center StudyCurrent Oncology 2023; 30(12): 10509 doi: 10.3390/curroncol30120766
6
Arif Ali Mandal, Rajesh Kushwaha, Ashish Kumar Yadav, Samya Banerjee. Metal Complexes for Cancer Sonodynamic TherapyChemBioChem 2023; 24(6) doi: 10.1002/cbic.202200597
7
Yuqian Wang, Lingeng Lu, Changquan Ling, Ping Zhang, Rui Han. Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 InhibitorsNutrients 2023; 15(18): 3984 doi: 10.3390/nu15183984
8
Katherine P. Lee, Benjamin Epstein, Camille M. Lake, Andrew L. Snow. Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytesFrontiers in Cell Death 2023; 2 doi: 10.3389/fceld.2023.1281137
9
Katia Roque, Rossana Ruiz, Luis Mas, Daniel Humberto Pozza, Marina Vancini, José Antônio Silva Júnior, Ramon Andrade de Mello. Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best ChoicesCancers 2023; 15(18): 4547 doi: 10.3390/cancers15184547
10
Botle Precious Damane, Zilungile Lynette Mkhize-Kwitshana, Mahlatse Cordelia Kgokolo, Thifhelimbilu Luvhengo, Zodwa Dlamini. Artificial Intelligence and Precision Oncology2023; : 239 doi: 10.1007/978-3-031-21506-3_12
11
Raphael Yip, Gaston Arnolda, Klay Lamprell, Bróna Nic Giolla Easpaig, Renuka Chittajallu, Geoff Delaney, Ian Olver, Winston Liauw, Jeffrey Braithwaite. Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative researchJournal for ImmunoTherapy of Cancer 2024; 12(1): e007555 doi: 10.1136/jitc-2023-007555
12
Amedeo De Grado, Federica Cencini, Alberto Priori. Neurology of cancer immunotherapyNeurological Sciences 2023; 44(1): 137 doi: 10.1007/s10072-022-06297-0
13
Antonio Cristiano, Riccardo Belardi, Hajro Hajrullaj, Emiliano Fabiani, Giulia Falconi, Elisa Galossi, Sergio Bernardini, Maria Teresa Voso, Marzia Nuccetelli. Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromesInflammation Research 2023; 72(8): 1695 doi: 10.1007/s00011-023-01773-5
14
Nourridine Siewe, Avner Friedman, Albert Rübben. Optimal timing of steroid initiation in response to CTLA-4 antibody in metastatic cancer: A mathematical modelPLOS ONE 2022; 17(11): e0277248 doi: 10.1371/journal.pone.0277248
15
Sia Pei Ling, Long Chiau Ming, Jagjit Singh Dhaliwal, Madhu Gupta, Chrismawan Ardianto, Khang Wen Goh, Zahid Hussain, Naeem Shafqat. Role of Immunotherapy in the Treatment of Cancer: A Systematic ReviewCancers 2022; 14(21): 5205 doi: 10.3390/cancers14215205
16
Wilma Barcellini, Bruno Fattizzo. Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” QuestionFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.751630
17
Ana Bagues, Yolanda López-Tofiño, Álvaro Llorente-Berzal, Raquel Abalo. Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal modelsBehavioural Pharmacology 2022; 33(2&3): 105 doi: 10.1097/FBP.0000000000000667
18
Idit Sagiv-Barfi, Debra K. Czerwinski, Tanaya Shree, Julian J. K. Lohmeyer, Ronald Levy. Intratumoral immunotherapy relies on B and T cell collaborationScience Immunology 2022; 7(71) doi: 10.1126/sciimmunol.abn5859
19
Shane S. Scott, Ashley N. Greenlee, Ethan J. Schwendeman, Somayya J. Mohammad, Michael T. Naughton, Anna Matzko, Mamadou Diallo, Matthew Stein, Rohith Revan, Taborah Z. Zaramo, Gabriel Shimmin, Shwetabh Tarun, Joel Ferrall, Thai H. Ho, Sakima A. Smith. Cardiovascular Signaling in Health and Disease2022; : 111 doi: 10.1007/978-3-031-08309-9_4
20
Kangwook Lee, Yu-Jeong Choi, Hae-In Lim, Kwang Jin Cho, Nuri Kang, Seong-Gyu Ko. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancerBMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04347-y
21
Chih-Rong Shyr, Lang-Chi Liu, Hui-Shan Chien, Chi-Ping Huang. Immunotherapeutic Agents for Intratumoral ImmunotherapyVaccines 2023; 11(11): 1717 doi: 10.3390/vaccines11111717
22
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Eugenio Sánchez-Arreola. Activities against Lung Cancer of Biosynthesized Silver Nanoparticles: A ReviewBiomedicines 2023; 11(2): 389 doi: 10.3390/biomedicines11020389
23
William Karlsen, Lin Akily, Monika Mierzejewska, Jacek Teodorczyk, Artur Bandura, Renata Zaucha, Wojciech Cytawa. Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and ConsCancers 2024; 16(11): 1990 doi: 10.3390/cancers16111990
24
Corrine Ying Xuan Chua, Dixita Ishani Viswanath, David P. Huston, Alessandro Grattoni. Engineering platforms for localized long-acting immune modulationJournal of Allergy and Clinical Immunology 2024; 153(3): 572 doi: 10.1016/j.jaci.2024.01.004
25
Hilde M. Buiting, Gabe S. Sonke. NaturalJournal of Surgical Oncology 2024; 129(7): 1177 doi: 10.1002/jso.27628
26
Stephanie Valente, Erin Roesch. Breast cancer survivorshipJournal of Surgical Oncology 2024;  doi: 10.1002/jso.27627
27
Xi Chen, Zhijie Xu, Tongfei Li, Abhimanyu Thakur, Yu Wen, Kui Zhang, Yuanhong Liu, Qiuju Liang, Wangrui Liu, Jiang-Jiang Qin, Yuanliang Yan. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapyBiomarker Research 2024; 12(1) doi: 10.1186/s40364-023-00551-z
28
Abegaz Tizazu Andrgie, Hsieh-Chih Tsai. Hydrogels as local depots for on-demand therapeutic delivery: potential therapeutic approaches for tumor metastasisMaterials Advances 2024; 5(9): 3629 doi: 10.1039/D4MA00122B
29
Natashya Falcone, Menekse Ermis, Ankit Gangrade, Auveen Choroomi, Patric Young, Tess G. Mathes, Mahsa Monirizad, Fatemeh Zehtabi, Marvin Mecwan, Marco Rodriguez, Yangzhi Zhu, Youngjoo Byun, Ali Khademhosseini, Natan Roberto de Barros, Han‐Jun Kim. Drug‐Eluting Shear‐Thinning Hydrogel for the Delivery of Chemo‐ and Immunotherapeutic Agents for the Treatment of Hepatocellular CarcinomaAdvanced Functional Materials 2024; 34(8) doi: 10.1002/adfm.202309069
30
Saurabh Shah, Paras Famta, Anamika Sharma, Rahul Kumar, Giriraj Pandey, Ganesh Vambhurkar, Dadi A. Srinivasarao, Akshay Shinde, Sajja Bhanu Prasad, Amit Asthana, Saurabh Srivastava. Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancerDrug Delivery and Translational Research 2024;  doi: 10.1007/s13346-024-01592-z